Molecular aspects of MERS-CoV

Area of Science:

• Virology
• Infectious Diseases
• Public Health

Background:

• Middle East respiratory syndrome coronavirus (MERS-CoV) is a deadly betacoronavirus first identified in 2012.
• Over 1700 cases and 600 deaths have been reported globally, primarily in Saudi Arabia.
• MERS-CoV transmission is linked to dromedary camels and human-to-human contact, often in healthcare settings.

Purpose of the Study:

• To summarize the epidemiology, transmission, and current research efforts for MERS-CoV.
• To highlight the need for effective prevention, control, and therapeutic strategies.
• To review the progress in developing vaccines and treatments for MERS-CoV.

Main Methods:

• Literature review of MERS-CoV cases, transmission dynamics, and scientific research.
• Analysis of MERS-CoV origins and evolutionary factors.
• Overview of ongoing therapeutic and vaccine development initiatives.

Main Results:

• Most MERS-CoV cases originate from Saudi Arabia, with dromedary camels as a likely intermediate host.
• Human-to-human transmission necessitates strict infection control, especially in hospitals.
• Several therapeutic agents (e.g., nitazoxanide) and vaccine candidates (e.g., GLS-5300, m336) show promise.

Conclusions:

• Continued vigilance and improved infection control are crucial for managing MERS-CoV.
• Further research and development are essential to combat MERS-CoV effectively.
• Promising therapeutic and vaccine candidates offer hope for future MERS-CoV prevention and treatment.